跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,095 条关于
“FA-HNSCC”
全部
1,095
临床试验
595
药物
30
机构
255
资讯
215
去年
First-Ever Clinical Trial Launches to Test Afatinib in Fanconi Anemia-Associated Head and Neck Cancer
去年
PTC Therapeutics Plans FDA Submission for Vatiquinone in Friedreich's Ataxia
去年
OncoPrism-HNSCC RNA Test Shows Improved Prediction of Immunotherapy Response in Head and Neck Cancer
去年
OncoPrism-HNSCC Demonstrates Improved Prediction of Immunotherapy Response in Head and Neck Cancer
去年
Cofactor Genomics' OncoPrism-HNSCC Demonstrates Improved Prediction of Immunotherapy Response in Head and Neck Cancer
5个月前
Three Novel Therapies Target Frail HNSCC Patients Unable to Tolerate Standard Treatment
去年
Durvalumab Fails to Improve Outcomes Over Cetuximab in Head and Neck Cancer
2年前
PDS Biotech's Versamune HPV Plus Keytruda Shows Promising Results in HPV16-Positive Head and Neck Cancer
上个月
Inhibrx Advances Ozekibart Toward FDA Decision as PFS Data in HNSCC Looms
8天前
Immutep Refocuses Eftilagimod Alfa Development on HNSCC With CPS <1 and Neoadjuvant Soft Tissue Sarcoma
第 1 页,共 22 页
上一页
下一页